Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Resistance to targeted molecular therapies—both primary and acquired—remains a major obstacle to effective cancer treatment. Despite extensive research, the molecular determinants of treatment resistance are still incompletely understood, underscoring the need to identify robust resistance drivers to improve therapeutic outcomes. Recently, the ProCan and Wellcome Sanger Institute released the worl...
Pancreatic ductal adenocarcinoma (PDAC) lacks reliable prognostic biomarkers. RNA-based signatures suffer from poor reproducibility due to batch effects and platform heterogeneity between microarray and RNA-seq data, limiting machine learning applications. We developed a computational pipeline harmonizing RNA-seq data from multiple repositories using ComBat batch correction, followed by Random For...
Acute myeloid leukemia (AML) is a hematological cancer characterized by genetic diversity and poor clinical outcomes. Among various genetic mutations ...
Relapse risk in endometrial carcinoma (EC) is strongly influenced by molecular subtype, yet current WHO/ESGO classifications rely on postoperative dat...
Effective lung cancer detection from CT scans remains critically challenged by class imbalance where benign and normal cases are underrepresented, lea...
Cells must adopt flexible regulatory strategies to make decisions regarding their fate, including differentiation, apoptosis, or survival in the face ...
This work introduces a modular, open-source computational pipeline for glioblastoma (GBM) vaccine design that integrates omics-based OIP5 target disco...
Extracellular vesicles (EVs) mediate tumor-immune cell communication by carrying protein cargo that can immediately modulate signaling and antigen pre...
To train and validate a machine learning model to distinguish paper mill publications from genuine cancer research articles, and to screen the cancer ...
Prostate cancer is the second most common cancer in men across the United States, of which prostate adenocarcinoma (PRAD) is the most common subtype. ...
Due to the late detection, aggressive nature, and paucity of treatment options, pancreatic adenocarcinoma (PAAD) remains one of the most lethal cancer...
Epigenetic clocks estimate chronological and biological age from DNA methylation patterns, but conventional models typically train on hundreds of thou...
Bladder cancer exhibits sex-specific behavior, occurring more frequently in males but progressing to advanced stages more commonly in females. The act...
Synthetic enhancers with high specificity are crucial for therapeutic gene control. Although existing experimental screens and machine learning-based ...
Diffuse midline glioma (DMG) is a near-universally lethal form of pediatric high-grade glioma, driven by neuronal activity-regulated paracrine signali...
Breast cancer remains one of the leading causes of cancer-related mortality worldwide, with early detection being crucial for improved patient outcome...
Dissecting the heterogeneous response of individual cells towards genetic and chemical perturbations is central to understanding the dynamic functions...
Accurate breast cancer molecular subtyping is critical for treatment decisions, yet standard methods such as immunohistochemistry and gene expression ...
This work introduces a modular, open-source computational pipeline for glioblastoma (GBM) vaccine design that integrates omics-based OIP5 target disco...
Oral squamous cell carcinoma (OSCC) progression has been increasingly linked to dysbiosis of the oral microbiome. We hypothesized that pathogenic vers...